OR WAIT null SECS
June 29, 2020
The expansions included enhancing high-speed automatic syringe assembly and labeling, vial labeling and cartoning, and auto-injector assembly.
June 25, 2020
The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000L.
June 22, 2020
The facility has dedicated manufacturing and packaging for oral solid dosage forms, liquids, creams, and ointments.
The company will invest $75 million into its Canton, MA, facility to expand its viral vector, gene therapy, and contract development and manufacturing capabilities.
June 18, 2020
The company will invest EUR 610 million (USD$682 million) into a new vaccine production site and research center in France.
June 17, 2020
Manufacturers are adapting with virtual work, remote monitoring, and re-evaluation of facility design to ensure worker safety.
June 16, 2020
The company is planning on adding up to 1.5 million sq. ft. of cGMP distribution space for COVID-19 shipments.
June 10, 2020
The investment will increase production lines for bulk drug substance and will add a fill/finish production line to the site.
June 09, 2020
Siemens and Exyte partner for fast-track construction of modular, automated, digitalized biopharmaceutical facilities.
June 04, 2020
The center will offer expertise in fill-finish optimization and analytical testing.